NASDAQ:IMMP - Immutep Limited
$1.92
 $0.04
+2.24%
4:00PM EDT
2019-04-18
Immutep Ltd, formerly Prima BioMed Ltd., is a biotechnology company. The Company is engaged in research, development and commercialization of licensed medical biotechnology. It is also focused on development of immunotherapeutic products. The Company operates through Cancer Immunotherapy segment. Its core technologies are based on the Lymphocyte-activation gene 3 (LAG-3) immune control mechanism, which is involved in regulation of the T cell immune response. Its product, IMP321, is in clinical development for the treatment of a range of cancer indications, such as Metastatic Breast Cancer. IMP321 is in Phase IIb trials for Metastatic Breast Cancer and is being studied in Phase I for the treatment of Metastatic Melanoma. The Company is also focused on development of other products, which include IMP701, an antibody for cancer, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  IMMP     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 69   203. 85   241. 91  
42 stocks rank:  3. 63 K 1. 44 K 1. 05 K
# analyst opinions:  3. 00   14. 51   13. 97  
mean recommendation:  2. 00   2. 09   2. 01  

quick ratio:  7. 19   5. 27   1. 81  
current ratio:  7. 34   5. 62   2. 25  

target price low:  2. 22   84. 80   115. 21  
target price avg:  2. 51   111. 51   137. 51  
target price high:  2. 86   135. 81   157. 84  
1-yr high:  3. 90   114. 23   138. 78  
last close:  1. 90   87. 66   116. 69  
50-day avg:  2. 18   95. 54   123. 44  
200-day avg:  2. 55   94. 25   121. 11  
1-yr low:  1. 81   72. 78   98. 34  
volume:  49. 88 K 4. 11 M 8. 07 M
50-day avg volume:  325. 82 K 2. 76 M 5. 02 M
200-day avg volume:  147. 98 K 2. 92 M 4. 59 M

1-day return:  1. 06 % -0. 41 % 0. 07 %
this week return:  -0. 52 % -5. 74 % -4. 11 %
12-wk return:  -9. 52 % 1. 61 % -0. 05 %
52-wk return:  2. 17 % 3. 12 % 8. 78 %

enterprise value (EV):  63. 54 M 48. 94 B 114. 64 B
market cap:  63. 47 M 43. 07 B 104. 73 B
debt/equity:  21. 30   46. 71   89. 62  

shares outstanding:  3. 03 B 571. 70 M 1. 24 B
shares:  30. 37 M 571. 81 M 1. 23 B
shares short:  157. 56 K 10. 17 M 13. 00 M
shares short prior month:  114. 58 K 9. 54 M 17. 33 M
short ratio:  0. 24   5. 41   3. 28  

book value:  0. 80   12. 78   26. 92  
price/book:  2. 37   3. 06   -1. 74  
gross profits:  -3. 14 M 8. 04 B 34. 86 B
operating margins:  0. 00 % -725. 35 % -89. 04 %
EBITDA margins:  -296. 62 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  -163. 90 % 37. 08 % 55. 70 %

1-yr max volatility:  14. 73 % --- ---
1-yr mean volatility:  0. 10 % 0. 03 % 0. 04 %

1-yr EPS:  -0. 40   2. 40   4. 10  
forward EPS:  -0. 27   3. 97   7. 13  
P/E:  -4. 75   13. 63   22. 72  
forward P/E:  -7. 04   -15. 95   13. 99  
PE/G:  0. 10   -1. 65   -1. 32  
growth:  -46. 20 % 127. 12 % 29. 61 %
earnings high:  -0. 00   1. 00   1. 66  
earnings avg:  -0. 00   0. 77   1. 53  
earnings low:  -0. 00   0. 50   1. 39  
revenue high:  8. 35 M 2. 68 B 10. 78 B
revenue avg:  3. 66 M 2. 59 B 10. 57 B
revenue low:  -0. 00   2. 49 B 10. 36 B
return on assets:  -24. 01 % -2. 75 % 4. 55 %
return on equity:  -56. 38 % -18. 45 % 5. 46 %
revenue growth:  -46. 20 % 92. 86 % 18. 96 %

beta (1yr vs S&P500):  0. 50   1. 25   0. 93  
sharpe (1yr):  0. 38   0. 37   0. 70  

held % insiders:  0. 00 % 6. 39 % 3. 38 %
held % institutions:  10. 32 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : IMMP
.    + 0.978 =         0.978 :: INITIAL WEIGHT
.   + 40.317 =        41.296 :: spline projection addition
.    x 1.431 =        59.112 :: industry recommendation factor
.    x 2.122 =       125.407 :: symbol recommendation factor
.    x 0.998 =       125.105 :: return on assets factor
.    x 0.994 =         124.4 :: return on equity factor
.    x 0.995 =       123.825 :: revenue growth factor
.    x 2.694 =       333.613 :: current ratio factor
.    x 1.078 =       359.557 :: quick ratio factor
.    x 2.019 =       726.004 :: short ratio factor
.    x 2.024 =      1469.251 :: price-to-book factor
.    x 1.207 =      1772.884 :: debt-to-equity factor
.    x 2.092 =      3708.672 :: P/E weight
.    x 1.766 =      6549.461 :: PE/G factor
.    x 1.302 =      8525.585 :: beta factor
.    x 0.383 =      3261.533 :: sharpe factor
.    x 1.422 =      4638.349 :: target low factor
.     x 1.19 =      5517.733 :: target mean factor
.    x 1.071 =      5909.621 :: target high factor
.     x 1.31 =      7740.941 :: industry 2-weeks return factor
.    x 0.926 =       7170.14 :: "drift" penalty 1 days ago
.     x 0.94 =      6742.327 :: "drift" penalty 4 days ago
.    x 0.959 =      6466.078 :: overall "drift" factor
.    x 0.853 =      5513.486 :: largest single-day jump factor
.    x 0.065 =        360.83 :: low price factor
.      x 1.0 =       360.772 :: factor hist industry gain for week 16
.   cubeRoot =         7.119 :: reduced to standardize
.   - 21.645 =         0.687 :: add/subtract for performance
.                      0.687 :: FINAL WEIGHT for NASDAQ:IMMP


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org